As of Jun 20
| +3.10 / +3.17%|
The 3 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 135.00, with a high estimate of 152.00 and a low estimate of 92.00. The median estimate represents a +33.62% increase from the last price of 101.03.
The current consensus among 5 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.